Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Gynecologic 1Genitourinary 1

Conditions

Obesity 9Endometrial Neoplasms 5Prostatic Neoplasms 2Overweight 2Endometrial Hyperplasia 2Diabetes Mellitus 2Breast Neoplasms 2Weight Loss 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Opioid-Related Disorders 1Metabolic Syndrome 1Lymphoma, Follicular 1Insulin Resistance 1Inflammation 1Hyperplasia 1Dyslipidemias 1Colorectal Neoplasms 1

Interventions

Tirzepatide 2Surveys and Questionnaires 2tislelizumab 1sofosbuvir-velpatasvir drug combination 1saxagliptin 1epalrestat 1donafenib 1dapagliflozin 1Urine Specimen Collection 1Standard of Care 1Specimen Handling 1Phlebotomy 1Patient Navigation 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1Blood Specimen Collection 1Biopsy 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Diabetes Mellitus × Tirzepatide × 1 year × Clear all
NCT06751589 2026-04-13

A Study of a Weight Loss Intervention in People With Endometrial Cancer

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Recruiting
36 enrolled
GynecologicOther

Diabetes Mellitus, Obesity, Endometrial Neoplasms, Overweight

NCT06759701 2026-02-27

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
Genitourinary

Diabetes Mellitus, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡